130 related articles for article (PubMed ID: 2523357)
1. Inhibition of human eosinophil chemotaxis and of the IgE-dependent stimulation of human blood platelets by cetirizine.
De Vos C; Joseph M; Leprevost C; Vorng H; Tomassini M; Capron M; Capron A
Int Arch Allergy Appl Immunol; 1989; 88(1-2):212-5. PubMed ID: 2523357
[TBL] [Abstract][Full Text] [Related]
2. Inhibition of eosinophil chemotaxis by a new antiallergic compound (cetirizine).
Leprevost C; Capron M; De Vos C; Tomassini M; Capron A
Int Arch Allergy Appl Immunol; 1988; 87(1):9-13. PubMed ID: 2971624
[TBL] [Abstract][Full Text] [Related]
3. The inhibiting effect of cetirizine 2 HC1 on eosinophil migration and its link to H1 blockade.
Rihoux JP
Agents Actions Suppl; 1991; 33():409-15. PubMed ID: 1675836
[TBL] [Abstract][Full Text] [Related]
4. In vivo effects of cetirizine on cutaneous reactivity and eosinophil migration induced by platelet-activating factor (PAF-acether) in man.
Fadel R; David B; Herpin-Richard N; Borgnon A; Rassemont R; Rihoux JP
J Allergy Clin Immunol; 1990 Sep; 86(3 Pt 1):314-20. PubMed ID: 1976664
[TBL] [Abstract][Full Text] [Related]
5. Effects of cetirizine on human eosinophil and neutrophil activation in vitro.
Walsh GM; Moqbel R; Hartnell A; Kay AB
Int Arch Allergy Appl Immunol; 1991; 95(2-3):158-62. PubMed ID: 1682275
[TBL] [Abstract][Full Text] [Related]
6. Effect of cetirizine on human eosinophil superoxide generation, eosinophil chemotaxis and eosinophil peroxidase in vitro.
Okada C; Eda R; Miyagawa H; Sugiyama H; Hopp RJ; Bewtra AK; Townley RG
Int Arch Allergy Immunol; 1994; 103(4):384-90. PubMed ID: 8130652
[TBL] [Abstract][Full Text] [Related]
7. Additional properties of cetirizine, a new H1 antagonist.
Naclerio RM
Allergy Proc; 1991; 12(3):187-91. PubMed ID: 1680095
[TBL] [Abstract][Full Text] [Related]
8. Use of cetirizine to investigate non-H1 effects of second-generation antihistamines.
Townley RG; Okada C
Ann Allergy; 1992 Feb; 68(2):190-6. PubMed ID: 1346737
[TBL] [Abstract][Full Text] [Related]
9. The effect of WEB 2086 on PAF-induced eosinophil chemotaxis and LTC4 production from eosinophils.
Miyagawa H; Nabe M; Hopp RJ; Okada C; Bewtra AK; Townley G
Agents Actions; 1992 Sep; 37(1-2):39-43. PubMed ID: 1456179
[TBL] [Abstract][Full Text] [Related]
10. Pharmacological modulation by cetirizine and loratadine of antigen and histamine-induced skin weals and flares, and late accumulation of eosinophils.
Fadel R; Herpin-Richard N; Dufresne F; Rihoux JP
J Int Med Res; 1990; 18(5):366-71. PubMed ID: 2147913
[TBL] [Abstract][Full Text] [Related]
11. Inhibitory effect of cetirizine 2HCl on eosinophil migration in vivo.
Fadel R; Herpin-Richard N; Rihoux JP; Henocq E
Clin Allergy; 1987 Jul; 17(4):373-9. PubMed ID: 2887304
[TBL] [Abstract][Full Text] [Related]
12. Upregulation of formyl-peptide and interleukin-8-induced eosinophil chemotaxis in patients with allergic asthma.
Warringa RA; Mengelers HJ; Raaijmakers JA; Bruijnzeel PL; Koenderman L
J Allergy Clin Immunol; 1993 Jun; 91(6):1198-205. PubMed ID: 8509580
[TBL] [Abstract][Full Text] [Related]
13. Eosinophil migration in atopic dermatitis. I: Increased migratory responses to N-formyl-methionyl-leucyl-phenylalanine, neutrophil-activating factor, platelet-activating factor, and platelet factor 4.
Bruijnzeel PL; Kuijper PH; Rihs S; Betz S; Warringa RA; Koenderman L
J Invest Dermatol; 1993 Feb; 100(2):137-42. PubMed ID: 8429236
[TBL] [Abstract][Full Text] [Related]
14. Cetirizine inhibits the in vitro and ex vivo chemotactic response of T lymphocytes and monocytes.
Jinquan T; Reimert CM; Deleuran B; Zachariae C; Simonsen C; Thestrup-Pedersen K
J Allergy Clin Immunol; 1995 May; 95(5 Pt 1):979-86. PubMed ID: 7751519
[TBL] [Abstract][Full Text] [Related]
15. Platelet-activating factor-induced immediate and late cutaneous reactions.
Rihoux JP; Fadel R; Juhlin L
Int Arch Allergy Appl Immunol; 1991; 94(1-4):299-300. PubMed ID: 1834582
[TBL] [Abstract][Full Text] [Related]
16. Effects of lipoxin A4 on chemotaxis and degranulation of human eosinophils stimulated by platelet-activating factor and N-formyl-L-methionyl-L-leucyl-L-phenylalanine.
Soyombo O; Spur BW; Lee TH
Allergy; 1994 Apr; 49(4):230-4. PubMed ID: 8037356
[TBL] [Abstract][Full Text] [Related]
17. Inhibitory effect of oral cetirizine on in vivo antigen-induced histamine and PAF-acether release and eosinophil recruitment in human skin.
Michel L; De Vos C; Rihoux JP; Burtin C; Benveniste J; Dubertret L
J Allergy Clin Immunol; 1988 Jul; 82(1):101-9. PubMed ID: 2899102
[TBL] [Abstract][Full Text] [Related]
18. The effect of cetirizine on antigen-dependent leucopenia in the guinea-pig.
Coyle AJ; Lefort J; Vargaftig BB
Br J Pharmacol; 1991 Jun; 103(2):1520-4. PubMed ID: 1679361
[TBL] [Abstract][Full Text] [Related]
19. Inhibitory effects of formoterol on platelet-activating factor induced eosinophil chemotaxis and degranulation.
Eda R; Sugiyama H; Hopp RJ; Okada C; Bewtra AK; Townley RG
Int Arch Allergy Immunol; 1993; 102(4):391-8. PubMed ID: 8241801
[TBL] [Abstract][Full Text] [Related]
20. Cetirizine: a new H1 antagonist with antieosinophilic activity in chronic urticaria.
Townley RG
J Am Acad Dermatol; 1991 Oct; 25(4):668-74. PubMed ID: 1686439
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
